Alkermes to manufacture drugs in Athlone for ‘top pharmaceutical firm’

ALKERMES Plc says it will manufacture drugs in Athlone for “one of the world’s top 10 pharmaceutical companies” in a deal that may generate from $15 million to $20m (€11m-€15m) in annual revenue by 2016.

Alkermes will make the finished product in Athlone, Ireland, at a plant acquired through its merger with Elan Drug Technologies, the company said yesterday.

Alkermes, whose headquarters officially moved to Dublin from Waltham, Massachusetts, yesterday, declined to name the customer.